Position in ALKS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$41,972
New position
Shares Held
801
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#335
of 423 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Uniplan Investment Counsel, Inc. holds $6,293,960 across 3 Drug Manufacturers - Specialty & Generic names. ALKS ranks #3 (0.7% of the industry book) .
All Filings in ALKS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,972 | 801 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||